Edition:
United States

Varian Medical Systems Inc gives Q2 2016 guidance; updates FY 2016 EPS guidance; reaffirms FY 2016 revenue guidance


Wednesday, 27 Jan 2016 04:02pm EST 

Varian Medical Systems Inc:Including effects of R&D tax credit re-enactment and suspension of medical device excise tax in U.S., co believe that for FY 2016 total company non-GAAP earnings will be in the range of $4.55 to $4.65 per diluted share.Continues to expect that revenues for Fy 2016 will increase by about 4 to 5 percent over FY 2015.Says For Q2 2016, expect revenues to be up one to two percent from the year-ago quarter in dollars.expect non-GAAP earnings for Q2 2016 to be in the range of $1.06 to $1.10 per diluted share.